<p>Summary of linear mixed-effects model results. For each OCTA-derived metric and device (DREAM, Cirrus, Triton), linear mixed-effects models were fitted with segmentation offset (measured in µm) as
Version 1Summary of linear mixed-effects model results. For each OCTA-derived metric and device (DREAM, Cirrus, Triton), linear mixed-effects models were fitted with segmentation offset (measured in µm) as a continuous predictor. Separate models were created for each device and vascular plexus (Superficial Capillary Plexus [SCP] and Deep Capillary Plexus [DCP]). Table entries include the model intercept, slope (i.e., effect per 1 µm offset), associated p-value, and the predicted change in the metric at +
No license available
Summary of linear mixed-effects model results. For each OCTA-derived metric and device (DREAM, Cirrus, Triton), linear mixed-effects models were fitted with segmentation offset (measured in µm) as a continuous predictor. Separate models were created for each device and vascular plexus (Superficial Capillary Plexus [SCP] and Deep Capillary Plexus [DCP]). Table entries include the model intercept, slope (i.e., effect per 1 µm offset), associated p-value, and the predicted change in the metric at +